Log In / Sign Up

SB 1323

  • Tennessee Senate Bill
  • 110th Regular Session (2017-2018)
  • Introduced in Senate Feb 09, 2017
  • Senate
  • House
  • Governor

Controlled Substances - As introduced, requires the commissioner of health, in consultation with the commissioner of mental health and substance abuse services, to study and report to the health committee of the house of representatives and the health and welfare committee of the senate, on or before January 15, 2018, concerning any recommended changes to prescribing guidelines for buprenorphine products, or to Tennessee Code Annotated, Section 53-11-311. - Amends TCA Title 53, Chapter 11, Part 3.

View Latest Bill Text
Sign In to Follow

Bill Subjects

Controlled Substances

Abstract

Bill Sponsors (2)

Gary Hicks

  • Republican
  • Representative
  • District 9
Primary

Steven Dickerson

  • Republican
Primary

Votes

No votes to display

Actions

Feb 15, 2017

House

Assigned to s/c Health Subcommittee

House

P2C, ref. to Health Committee

Feb 13, 2017

Senate

Passed on Second Consideration, refer to Senate Health and Welfare Committee

House

P1C.

Feb 09, 2017

House

Intro.

Senate

Introduced, Passed on First Consideration

Senate

Filed for introduction

House

Filed for intro.

Bill Text

Bill Text Versions Format
Current Version PDF

Related Documents

Document Format
No related documents.

Sources

Data on Open States is updated periodically throughout the day from the official website of the Tennessee General Assembly.

If you notice any inconsistencies with these official sources, feel free to file an issue.